Logo do repositório
 
Publicação

Improving the understanding of late effects of testicular cancer in adolescent and young adult survivors: TRANSCEND-XR

2026-01-01Artigo de investigação Acesso aberto
Ver registo simples
dc.contributor.authorSaab, Mohamad M.
dc.contributor.authorHegarty, Josephine
dc.contributor.authorGleeson, Jack P.
dc.contributor.authorMurphy, David
dc.contributor.authorMcHugh, Sheena
dc.contributor.authorShiely, Frances
dc.contributor.authorMurphy, Aileen
dc.contributor.authorKirby, Ann
dc.contributor.authorKorfage, Ida J.
dc.contributor.authorTerhaard, Sophie
dc.contributor.authorHeide, Agnes van der
dc.contributor.authorSivesgaard, Johannes
dc.contributor.authorSeidler, Matias Katajavaara
dc.contributor.authorPatrikidou, Anna
dc.contributor.authorJežek, Davor
dc.contributor.authorCorrigan, Lynda
dc.contributor.authorSheehan, Patrice Kearney
dc.contributor.authorRaggi, Daniele
dc.contributor.authorReid, Alison
dc.contributor.authorChovanec, Michal
dc.contributor.authorGianntempo, Patrizia
dc.contributor.authorGietema, Jourik A.
dc.contributor.authorFeen, Justine Fleur van der
dc.contributor.authorLupiáñez-Villanueva, Francisco
dc.contributor.authorRoca-Umbert, Ana
dc.contributor.authorReid, Joanne
dc.contributor.authorAlves, Paulo
dc.contributor.authorSoares, Joana
dc.contributor.authorGalvin, Karen
dc.contributor.authorKubo, Michal
dc.contributor.authorO'Malley, Maria
dc.date.accessioned2026-06-05T16:19:54Z
dc.date.available2026-06-05T16:19:54Z
dc.date.issued2026-01-01
dc.description.abstractBackground: Testicular cancer (TC) is the most common malignancy amongst adolescents and young adults (AYAs) aged 15–39 years assigned male at birth. Survivors often experience late effects of treatment and report unmet supportive care needs. Objectives: To present the protocol for the TRANSCEND-XR project (TesticulaR cANcer late effects and unmet Supportive CarE NeeDs of AYA survivors using eXtended Reality). Materials and Methods: TRANSCEND-XR aims to ethically co-create, test, and scale up in a clinical setting an innovative digital intervention to increase AYA TC survivors’ knowledge of the late effects of TC treatment and address their unmet supportive care needs using XR. Delivered by a consortium of 15 partners across 12 European countries, guided by the Medical Research Council's framework for complex interventions, and funded by the European Union, TRANSCEND-XR is structured into three phases: co-creation and validation (Phase 1); implementation and evaluation (Phase 2); and impact, guideline development, policy, dissemination, and exploitation (Phase 3). Results: Phase 1 involves a cross-sectional survey of 500 AYA TC survivors to assess late effects and care needs as well as participatory World Café sessions with healthcare professionals, survivors, and care partners (n = 200) to co-design the TRANSCEND-XR intervention. Phase 2 includes a multicentre, single-arm phase 2 pilot trial (n = 15) across three clinical sites in three countries evaluating intervention feasibility, and a multicentre pragmatic randomised controlled phase 3 trial (n = 230) across eight clinical sites in seven countries, evaluating improvements in knowledge of late effects, cost-effectiveness, implementation, and ethical considerations. Phase 3 focuses on guideline development, policy influence, and strategic dissemination to ensure long-term sustainability and integration into European healthcare systems. Discussion: TRANSCEND-XR aims to transform survivorship care for AYA TC survivors through a co-created, scalable XR intervention. Its interdisciplinary approach promotes scientific rigour, stakeholder engagement, and policy relevance to improve long-term outcomes and quality of life. Conclusion: TRANSCEND-XR has the potential to advance survivorship care standards for AYAs with TC whilst providing a model for future digital health interventions in oncology.eng
dc.identifier.doi10.1111/andr.70263
dc.identifier.eid105039667433
dc.identifier.otherc95d38be-4dfd-4334-988e-535547efcdbb
dc.identifier.pmid42179065
dc.identifier.urihttp://hdl.handle.net/10400.14/57980
dc.identifier.wos001772924600001
dc.language.isoeng
dc.peerreviewedyes
dc.publisherJohn Wiley & Sons Inc.
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subjectAdolescenteng
dc.subjectExtended realityeng
dc.subjectLate effectseng
dc.subjectTesticular neoplasmseng
dc.subjectVirtual realityeng
dc.subjectYoung adulteng
dc.titleImproving the understanding of late effects of testicular cancer in adolescent and young adult survivors: TRANSCEND-XR
dc.typeresearch article
dspace.entity.typePublication
oaire.versionhttp://purl.org/coar/version/c_ab4af688f83e57aa

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura
Nome:
151747167.pdf
Tamanho:
1.06 MB
Formato:
Adobe Portable Document Format
Ver/Abrir

Coleções

CIIS - Contribuições em Revistas Científicas / Contribution to Journals